Skip to main content
VCbacked
Log inGet Started

Rapafusyn Pharmaceuticals

Baltimore, United States

Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.

$16.0M raised
Sep 2025
Series A
Biotechnology

Top Investors

3E BioventuresLapam CapitalBioTrack CapitalProx VenturesYonjin Venture

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rapafusyn Pharmaceuticals

How much funding has Rapafusyn Pharmaceuticals raised?
Rapafusyn Pharmaceuticals has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
Who are Rapafusyn Pharmaceuticals's investors?
Rapafusyn Pharmaceuticals's investors include 3E Bioventures, Lapam Capital, BioTrack Capital, Prox Ventures, Yonjin Venture.
Where is Rapafusyn Pharmaceuticals headquartered?
Rapafusyn Pharmaceuticals is headquartered in Baltimore, United States.
What does Rapafusyn Pharmaceuticals do?
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.
What stage is Rapafusyn Pharmaceuticals at?
Rapafusyn Pharmaceuticals is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Rapafusyn Pharmaceuticals — Funding & Investors." VCBacked, September 4, 2025, https://www.vcbacked.co/company/rapafusyn-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2025). Rapafusyn Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/rapafusyn-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Rapafusyn Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/rapafusyn-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K